Part 6: Gut Dysbiosis: Causes, Symptoms & How to Restore Balance

A comprehensive look at what disrupts the gut ecosystem, what it means for your health, and how to rebuild a resilient microbiome

Part 6 of the Your Gut, Your Health series. Start at the beginning: Gut Microbiome Testing →

Dysbiosis — the disruption of microbial balance — is the common thread underlying many of the associations discussed throughout this series. Understanding it in depth, knowing its causes, recognising its presentations, and appreciating the evidence behind restoration strategies, provides a complete framework for approaching gut health with precision.

1. Defining Dysbiosis: More Than Just "Bad Bacteria"

Dysbiosis encompasses three distinct but overlapping phenomena:

Loss of microbial diversity. When diversity drops, the ecosystem loses redundancy and resilience. Functions previously performed by a range of species may become impaired.

Absence or depletion of key beneficial species. Faecalibacterium prausnitzii produces butyrate and has strong anti-inflammatory properties. Akkermansia muciniphila maintains gut lining integrity. Bifidobacterium species support immune function. Their loss is clinically significant.

Overgrowth of pathobionts. Pathobionts are microorganisms normally present in small amounts without causing harm, but which become problematic when they proliferate disproportionately — disrupting epithelial barrier function and activating inflammatory pathways.

2. The Major Causes of Dysbiosis

Antibiotics remain the most rapid and dramatic disruptors. A single course of broad-spectrum antibiotics can eliminate hundreds of species within days, and certain species never fully recover.

Dietary patterns are the primary long-term determinants. A sustained Western dietary pattern — high in ultra-processed foods and low in plant diversity and fibre — is the single most prevalent driver of population-level microbiome decline.

Psychological and physiological stress alter gut function through HPA axis activation, changing gut motility, mucus production, and the gut immune environment.

Medications beyond antibiotics — proton pump inhibitors, metformin, NSAIDs, antidepressants — each have documented effects on gut microbial composition.

Infections including gastroenteritis, C. difficile, parasitic infections, and significant viral illness can produce acute dysbiosis that in some individuals transitions into chronic post-infectious patterns.

Age is an independent driver. Gut microbiome diversity peaks in young adulthood and declines gradually, with more pronounced changes after approximately 65 years.

3. How Dysbiosis Drives Disease

Impaired gut barrier function. Loss of butyrate-producing species impairs tight junction proteins, allowing bacterial products, incompletely digested food particles, and toxins to enter systemic circulation.

Metabolic endotoxaemia. LPS from gram-negative bacteria circulating systemically produces chronic, low-grade inflammation — a driver of insulin resistance, cardiovascular risk, neuroinflammation, and fatty liver disease.

Altered short-chain fatty acid production. Dysbiosis reliably reduces SCFA output — particularly butyrate — with downstream effects on colonocyte health, gut barrier integrity, and systemic inflammation.

Disrupted immune regulation. Approximately 70% of the body's immune tissue is located in the gut. Dysbiosis disrupts immune education and regulation, contributing to both chronic inflammatory states and impaired pathogen defence.

4. Recognising Dysbiosis: Clinical Presentations

Gastrointestinal: Persistent bloating, flatulence, variable bowel habits, incomplete evacuation, food sensitivities, nausea without identifiable structural cause.

Systemic inflammatory: Elevated CRP/ESR without clear aetiology, recurrent infections, autoimmune flares, unexplained fatigue.

Metabolic: Insulin resistance, elevated triglycerides, metabolic syndrome, weight gain resistant to dietary intervention.

Neurological and psychological: Brain fog, difficulty concentrating, mood instability, anxiety, and low mood — via the gut-brain axis as explored in Part 3.

Dermatological: Eczema, psoriasis, adult acne, and rosacea through the gut-skin axis.

The pattern of multiple seemingly unrelated symptoms across different body systems is the key clinical signal warranting microbiome investigation.

5. The Restoration Framework

Layer 1: Remove the Disruptors

Minimise ultra-processed foods, reduce alcohol, manage unnecessary antibiotic exposure, and address chronic stress. Without this foundational step, restorative interventions are fighting an ongoing headwind.

Layer 2: Rebuild with Diversity

Aim for 30+ different plant species per week — vegetables, legumes, whole grains, fruits, nuts, seeds, and herbs. Add regular fermented foods: yoghurt, kefir, kimchi, sauerkraut, miso.

Layer 3: Feed What You're Building

Dietary fibre is the essential substrate for the beneficial bacterial communities you are cultivating. Prebiotic supplementation (inulin, GOS, FOS) can support this where dietary fibre is insufficient.

Layer 4: Target Specific Deficiencies

Where comprehensive microbiome testing reveals specific depletions — low Akkermansia, reduced SCFA producers, elevated pathobionts — targeted interventions can address these gaps with greater precision.

Layer 5: Support Resilience

Consistent sleep timing, regular physical activity, effective stress management, and maintaining circadian alignment reduce the likelihood of dysbiosis recurrence after restoration.

Think of restoration as building a garden, not taking a medicine. Follow-up microbiome testing 3–6 months after beginning a structured restoration programme is the most reliable way to assess progress.

6. When to Seek Clinical Guidance

Seek assessment when gut symptoms have persisted for more than a few weeks, significantly affect quality of life, when you have a history of significant gut infection or repeated antibiotic courses, or when dysbiosis-related symptoms co-occur with autoimmune conditions, metabolic disease, or treatment-resistant mood disorders.

The 2025 international consensus from The Lancet Gastroenterology & Hepatology — involving 69 microbiome experts from 18 countries — recommended that microbiome tests should be prescribed and interpreted by licensed healthcare practitioners, and that clinical context is essential to making results meaningful.

Not Sure Which Test Is Right for You?

Use our free 2-minute screening tool to find the Microba Microbiome Explorer™ tier that best matches your symptoms and health goals.

Find My Test →

The Complete Series

• Part 1: Gut Microbiome Testing: What It Is & Who Needs One →
• Part 2: What Does Your Gut Microbiome Say About Your Health? →
• Part 3: The Gut-Brain Connection: How Your Microbiome Affects Mood, Anxiety & Mental Clarity →
• Part 4: How to Improve Your Gut Microbiome: Diet, Lifestyle & Evidence-Based Strategies →
• Part 5: The Gut Microbiome & Weight Loss: What the Science Actually Says →
• Part 6: Gut Dysbiosis: Causes, Symptoms & How to Restore Balance (you are here)

References

1. Shen, Y. et al. (2025). Gut microbiota dysbiosis: Pathogenesis, diseases, prevention, and therapy. MedComm. https://doi.org/10.1002/mco2.70168
2. Safarchi, A. et al. (2025). Understanding dysbiosis and resilience in the human gut microbiome. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1559521
3. Porcari, S. et al. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154–167. https://doi.org/10.1016/S2468-1253(24)00311-X
4. Holscher, H.D. (2017). Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes, 8(2), 172–184.
5. Tlaskalova-Hogenova, H. et al. (2022). Gut microbiota dysbiosis: Triggers, consequences, diagnostic and therapeutic options. Microorganisms, 10(3), 578.